Genomic Determinants of Pathogenicity and Antimicrobial Resistance of Nosocomial Acinetobacter baumannii Clinical Isolates of Hospitalized Patients (2019–2021) from a Sentinel Hospital in Hangzhou, China

References

• Martin-Aspas A, Guerrero-Sanchez FM, Garcia-Colchero F, Rodriguez-Roca S, Giron-Gonzalez JA. Differential characteristics of Acinetobacter baumannii colonization and infection: risk factors, clinical picture, and mortality. Infect Drug Resist. 2018;11:861–872. doi:10.2147/IDR.S163944
   PubMed Web of Science ®Google Scholar
• Morris FC, Dexter C, Kostoulias X, Uddin MI, Peleg AY. The mechanisms of disease caused by Acinetobacter baumannii. Front Microbiol. 2019;10:1601. doi:10.3389/fmicb.2019.01601
   PubMed Web of Science ®Google Scholar
• Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21(3):538–582. doi:10.1128/cmr.00058-07
   PubMed Web of Science ®Google Scholar
• Al-Kadmy IMS, Ali ANM, Salman IMA, Khazaal SS. Molecular characterization of Acinetobacter baumannii isolated from Iraqi hospital environment. New Microbes New Infect. 2018;21:51–57. doi:10.1016/j.nmni.2017.10.010
   PubMedGoogle Scholar
• Spellberg B, Rex JH. The value of single-pathogen antibacterial agents. Nat Rev Drug Discov. 2013;12(12):963. doi:10.1038/nrd3957-c1
   PubMed Web of Science ®Google Scholar
• Bianco A, Quirino A, Giordano M, et al. Control of carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit of a teaching hospital in Southern Italy. BMC Infect Dis. 2016;16(1):747. doi:10.1186/s12879-016-2036-7
   PubMedGoogle Scholar
• Zarrilli R, Casillo R, Di Popolo A, et al. Molecular epidemiology of a clonal outbreak of multidrug-resistant Acinetobacter baumannii in a university hospital in Italy. Clin Microbiol Infect. 2007;13(5):481–489. doi:10.1111/j.1469-0691.2006.01675.x
   PubMed Web of Science ®Google Scholar
• Yadav SK, Bhujel R, Hamal P, Mishra SK, Sharma S, Sherchand JB. Burden of multidrug-resistant Acinetobacter baumannii infection in hospitalized patients in a tertiary care hospital of Nepal. Infect Drug Resist. 2020;13:725–732. doi:10.2147/idr.S239514
   PubMed Web of Science ®Google Scholar
• Ibrahim S, Al-Saryi N, Al-Kadmy IMS, Aziz SN. Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals. Mol Biol Rep. 2021;48(10):6987–6998. doi:10.1007/s11033-021-06690-6
   PubMed Web of Science ®Google Scholar
• Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol. 2007;5(12):939–951. doi:10.1038/nrmicro1789
   PubMed Web of Science ®Google Scholar
• Lopinska A, Indykiewicz P, Skiebe E, et al. Low occurrence of Acinetobacter baumannii in gulls and songbirds. Pol J Microbiol. 2020;69:1–6. doi:10.33073/pjm-2020-011
   PubMed Web of Science ®Google Scholar
• Mateo-Estrada V, Vali L, Hamouda A, Evans BA, Castillo-Ramirez S. Acinetobacter baumannii sampled from cattle and pigs represent novel clones. Microbiol Spectr. 2022;10(4):e0128922. doi:10.1128/spectrum.01289-22
   PubMed Web of Science ®Google Scholar
• Harding CM, Hennon SW, Feldman MF. Uncovering the mechanisms of Acinetobacter baumannii virulence. Nat Rev Microbiol. 2018;16(2):91–102. doi:10.1038/nrmicro.2017.148
   PubMed Web of Science ®Google Scholar
• Ayoub Moubareck C, Hammoudi Halat D. Insights into Acinetobacter baumannii: a review of microbiological, virulence, and resistance traits in a threatening nosocomial pathogen. Antibiotics. 2020;9(3):119. doi:10.3390/antibiotics9030119
   Web of Science ®Google Scholar
• Gaddy JA, Actis LA. Regulation of Acinetobacter baumannii biofilm formation. Future Microbiol. 2009;4(3):273–278. doi:10.2217/fmb.09.5
   PubMed Web of Science ®Google Scholar
• Wareth G, Brandt C, Sprague LD, Neubauer H, Pletz MW. WGS based analysis of acquired antimicrobial resistance in human and non-human Acinetobacter baumannii isolates from a German perspective. BMC Microbiol. 2021;21(1):210. doi:10.1186/s12866-021-02270-7
   PubMed Web of Science ®Google Scholar
• Roberts LW, Forde BM, Hurst T, et al. Genomic surveillance, characterization and intervention of a polymicrobial multidrug-resistant outbreak in critical care. Microb Genom. 2021;7(3). doi:10.1099/mgen.0.000530
   PubMed Web of Science ®Google Scholar
• Hamidian M, Nigro SJ. Emergence, molecular mechanisms and global spread of carbapenem-resistant Acinetobacter baumannii. Microb Genom. 2019;5(10). doi:10.1099/mgen.0.000306
   Web of Science ®Google Scholar
• Cherubini S, Perilli M, Segatore B, et al. Whole-genome sequencing of ST2 A. baumannii causing bloodstream infections in COVID-19 patients. Antibiotics. 2022;11(7):955. doi:10.3390/antibiotics11070955
   Google Scholar
• Li Y, Kang X, Ed-Dra A, et al. Genome-based assessment of antimicrobial resistance and virulence potential of isolates of non-pullorum/gallinarum salmonella serovars recovered from dead poultry in China. Microbiol Spectr. 2022;10(4):e0096522. doi:10.1128/spectrum.00965-22
   PubMed Web of Science ®Google Scholar
• Pan H, Jia C, Paudyal N, et al. Comprehensive assessment of subtyping methods for improved surveillance of foodborne salmonella. Microbiol Spectr. 2022;10(5):e0247922. doi:10.1128/spectrum.02479-22
   PubMedGoogle Scholar
• Zhou W, Lin R, Zhou Z, et al. Antimicrobial resistance and genomic characterization of Escherichia coli from pigs and chickens in Zhejiang, China. Front Microbiol. 2022;13:1018682. doi:10.3389/fmicb.2022.1018682
   PubMedGoogle Scholar
• Tang B, Ni J, Lin J, et al. Genomic characterization of multidrug-resistance gene CFR in Escherichia coli recovered from food animals in Eastern China. Front Microbiol. 2022;13:999778. doi:10.3389/fmicb.2022.999778
   PubMed Web of Science ®Google Scholar
• Xu X, Chen Y, Pan H, et al. Genomic characterization of Salmonella Uzaramo for human invasive infection. Microb Genom. 2020;6(7). doi:10.1099/mgen.0.000401
   Web of Science ®Google Scholar
• Elbediwi M, Pan H, Biswas S, Li Y, Yue M. Emerging colistin resistance in Salmonella enterica serovar Newport isolates from human infections. Emerg Microbes Infect. 2020;9(1):535–538. doi:10.1080/22221751.2020.1733439
   PubMed Web of Science ®Google Scholar
• Clinical, Institute LS. Performance Standards for Antimicrobial Susceptibility Testing. Wayne, PA: Clinical and Laboratory Standards Institute; 2019.
   Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x
   PubMed Web of Science ®Google Scholar
• Van An N, Hoang LH, Le HHL, et al. Distribution and antibiotic resistance characteristics of bacteria isolated from blood culture in a teaching hospital in Vietnam during 2014–2021. Infect Drug Resist. 2023;16:1677–1692. doi:10.2147/IDR.S402278
   PubMed Web of Science ®Google Scholar
• Bankevich A, Nurk S, Antipov D, et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol. 2012;19(5):455–477. doi:10.1089/cmb.2012.0021
   PubMed Web of Science ®Google Scholar
• Afgan E, Baker D, van den Beek M, et al. The galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update. Nucleic Acids Res. 2016;44(W1):W3–W10. doi:10.1093/nar/gkw343
   PubMed Web of Science ®Google Scholar
• Biswas S, Elbediwi M, Gu G, Yue M. Genomic characterization of new variant of hydrogen sulfide (H(2)S)-producing Escherichia coli with multidrug resistance properties carrying the mcr-1 gene in China†. Antibiotics. 2020;9(2):80. doi:10.3390/antibiotics9020080
   Google Scholar
• Zankari E, Hasman H, Cosentino S, et al. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother. 2012;67(11):2640–2644. doi:10.1093/jac/dks261
   PubMed Web of Science ®Google Scholar
• Liu Q, Chen W, Elbediwi M, et al. Characterization of salmonella resistome and plasmidome in pork production system in Jiangsu, China. Front Vet Sci. 2020;7:617. doi:10.3389/fvets.2020.00617
   PubMed Web of Science ®Google Scholar
• Wu B, Ed-Dra A, Pan H, Dong C, Jia C, Yue M. Genomic investigation of salmonella isolates recovered from a pig slaughtering process in Hangzhou, China. Front Microbiol. 2021;12:704636. doi:10.3389/fmicb.2021.704636
   PubMed Web of Science ®Google Scholar
• Liu Y, Jiang J, Ed-Dra A, et al. Prevalence and genomic investigation of Salmonella isolates recovered from animal food-chain in Xinjiang, China. Food Res Int. 2021;142:110198. doi:10.1016/j.foodres.2021.110198
   PubMed Web of Science ®Google Scholar
• Carattoli A, Zankari E, García-Fernández A, et al. In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing. Antimicrob Agents Chemother. 2014;58(7):3895–3903. doi:10.1128/aac.02412-14
   PubMed Web of Science ®Google Scholar
• Liu B, Zheng D, Jin Q, Chen L, Yang J. VFDB 2019: a comparative pathogenomic platform with an interactive web interface. Nucleic Acids Res. 2019;47(D1):D687–d692. doi:10.1093/nar/gky1080
   PubMed Web of Science ®Google Scholar
• Siguier P, Perochon J, Lestrade L, Mahillon J, Chandler M. ISfinder: the reference centre for bacterial insertion sequences. Nucleic Acids Res. 2006;34(Databaseissue):D32–6. doi:10.1093/nar/gkj014
   PubMed Web of Science ®Google Scholar
• Letunic I, Bork P. Interactive tree of life (iTOL) v3: an online tool for the display and annotation of phylogenetic and other trees. Nucleic Acids Res. 2016;44(W1):W242–5. doi:10.1093/nar/gkw290
   PubMed Web of Science ®Google Scholar
• Nascimento M, Sousa A, Ramirez M, Francisco AP, Carrico JA, Vaz C. PHYLOViZ 2.0: providing scalable data integration and visualization for multiple phylogenetic inference methods. Bioinformatics. 2017;33(1):128–129. doi:10.1093/bioinformatics/btw582
   PubMed Web of Science ®Google Scholar
• Schober P, Boer C, Schwarte LA. Correlation coefficients: appropriate use and interpretation. Anesth Analg. 2018;126(5):1763–1768. doi:10.1213/ANE.0000000000002864
   PubMed Web of Science ®Google Scholar
• Girija ASS, Priyadharsini JV. Prevalence of Acb and non-Acb complex in elderly population with urinary tract infection (UTI). Acta Clin Belg. 2021;76(2):106–112. doi:10.1080/17843286.2019.1669274
   PubMed Web of Science ®Google Scholar
• Uwingabiye J, Lemnouer A, Baidoo S, et al. Intensive care unit-acquired Acinetobacter baumannii infections in a Moroccan teaching hospital: epidemiology, risk factors and outcome. Germs. 2017;7(4):193–205. doi:10.18683/germs.2017.1126
   PubMedGoogle Scholar
• Ferrer M, Torres A. Epidemiology of ICU-acquired pneumonia. Curr Opin Crit Care. 2018;24(5):325–331. doi:10.1097/MCC.0000000000000536
   PubMed Web of Science ®Google Scholar
• Zheng W, Yuan S, Li L. Analysis of hospital departmental distribution and antibiotic susceptibility of Acinetobacter isolated from sputum samples. Am J Infect Control. 2013;41(8):e73–6. doi:10.1016/j.ajic.2012.11.004
   PubMed Web of Science ®Google Scholar
• Alrahmany D, Omar AF, Harb G, El Nekidy WS, Ghazi IM. Acinetobacter baumannii infections in hospitalized patients, treatment outcomes. Antibiotics. 2021;10(6):630. doi:10.3390/antibiotics10060630
   Google Scholar
• Granata G, Taglietti F, Schiavone F, Petrosillo N. Durlobactam in the treatment of multidrug-resistant Acinetobacter baumannii infections: a systematic review. J Clin Med. 2022;11(12):3258. doi:10.3390/jcm11123258
   PubMed Web of Science ®Google Scholar
• Finegold SM. In vitro efficacy of beta-lactam/beta-lactamase inhibitor combinations against bacteria involved in mixed infections. Int J Antimicrob Agents. 1999;12(Suppl 1):S9-14;discussion S26–7. doi:10.1016/s0924-8579(99)00086-2
   Google Scholar
• Smolyakov R, Borer A, Riesenberg K, et al. Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment. J Hosp Infect. 2003;54(1):32–38. doi:10.1016/s0195-6701(03)00046-x
   PubMed Web of Science ®Google Scholar
• Lee CR, Lee JH, Park M, et al. Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options. Front Cell Infect Microbiol. 2017;7:55. doi:10.3389/fcimb.2017.00055
   PubMed Web of Science ®Google Scholar
• Sakoulas G, Rose W, Berti A, et al. Classical beta-lactamase inhibitors potentiate the activity of daptomycin against methicillin-resistant Staphylococcus aureus and colistin against Acinetobacter baumannii. Antimicrob Agents Chemother. 2017;61(2). doi:10.1128/AAC.01745-16
   Web of Science ®Google Scholar
• Wareth G, Linde J, Nguyen NH, et al. WGS-based analysis of carbapenem-resistant Acinetobacter baumannii in Vietnam and molecular characterization of antimicrobial determinants and MLST in Southeast Asia. Antibiotics. 2021;10(5):563. doi:10.3390/antibiotics10050563
   Google Scholar
• Heritier C, Poirel L, Fournier PE, Claverie JM, Raoult D, Nordmann P. Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii. Antimicrob Agents Chemother. 2005;49(10):4174–4179. doi:10.1128/AAC.49.10.4174-4179.2005
   PubMed Web of Science ®Google Scholar
• Chopjitt P, Kerdsin A, Takeuchi D, et al. Whole genome analysis of extensively drug-resistant Acinetobacter baumannii clinical isolates in Thailand. Infect Disord Drug Targets. 2021;21(5):e270421188042. doi:10.2174/1871526520999201116201911
   PubMedGoogle Scholar
• Levy-Blitchtein S, Roca I, Plasencia-Rebata S, et al. Emergence and spread of carbapenem-resistant Acinetobacter baumannii international clones II and III in Lima, Peru. Emerg Microbes Infect. 2018;7(1):119. doi:10.1038/s41426-018-0127-9
   PubMedGoogle Scholar
• Li J, Yu T, Luo Y, et al. Characterization of carbapenem-resistant hypervirulent Acinetobacter baumannii strains isolated from hospitalized patients in the mid-south region of China. BMC Microbiol. 2020;20(1):281. doi:10.1186/s12866-020-01957-7
   PubMedGoogle Scholar
• Allen JL, Tomlinson BR, Casella LG, Shaw LN. Regulatory networks important for survival of Acinetobacter baumannii within the host. Curr Opin Microbiol. 2020;55:74–80. doi:10.1016/j.mib.2020.03.001
   PubMed Web of Science ®Google Scholar
• Clemmer KM, Bonomo RA, Rather PN. Genetic analysis of surface motility in Acinetobacter baumannii. Microbiology. 2011;157(Pt 9):2534–2544. doi:10.1099/mic.0.049791-0
   PubMed Web of Science ®Google Scholar
• Tang J, Chen Y, Wang X, Ding Y, Sun X, Ni Z. Contribution of the AbaI/AbaR quorum sensing system to resistance and virulence of Acinetobacter baumannii clinical strains. Infect Drug Resist. 2020;13:4273–4281. doi:10.2147/IDR.S276970
   PubMed Web of Science ®Google Scholar
• Yoon EJ, Kim JO, Yang JW, et al. The blaOXA-23-associated transposons in the genome of Acinetobacter spp. represent an epidemiological situation of the species encountering carbapenems. J Antimicrob Chemother. 2017;72(10):2708–2714. doi:10.1093/jac/dkx205
   PubMed Web of Science ®Google Scholar
• Khurshid M, Rasool MH, Ashfaq UA, et al. Dissemination of bla(OXA-23)-harbouring carbapenem-resistant Acinetobacter baumannii clones in Pakistan. J Glob Antimicrob Resist. 2020;21:357–362. doi:10.1016/j.jgar.2020.01.001
   PubMed Web of Science ®Google Scholar
• Yu K, Zeng W, Xu Y, et al. Bloodstream infections caused by ST2 Acinetobacter baumannii: risk factors, antibiotic regimens, and virulence over 6 years period in China. Antimicrob Resist Infect Control. 2021;10(1):16. doi:10.1186/s13756-020-00876-6
   PubMed Web of Science ®Google Scholar